A sell-side partner of ours just sent us a 20+ year old Business Intelligence & Analytics company with a rock-solid track record and untapped growth potential. Key Highlights: • Revenue (2024): $1.62M • Adjusted EBITDA Margin: ~63% • Recurring Revenue: 63% (3-year median contracts, upfront annual payments) • Customer Retention: 94% • Debt-Free Balance Sheet • YoY Growth: 9.3% • High Client Retention & Continuity: 60% of customers have 2+ years left on contracts • Top 10 customers = 67% of 2025 revenue (owners will transition 1–2 years to ensure smooth handoff) Growth Levers: • Minimal paid marketing to date (primarily organic & referrals). • Certified partner with a Gartner-recognized analytics leader – strong co-marketing & deal flow. • Expansion opportunities in new verticals (pain management, orthopedics, surgical sciences, urology, etc.). • Industry tailwinds: $72B projected BI/analytics spend (2025–2026). Valuation: • Seeking a 3x–4x EBITDA multiple. • Strong upside for a growth-minded buyer to scale via marketing, channel partnerships, and vertical expansion. Why This Deal Stands Out: This is a rare chance to acquire a profitable, high-retention analytics platform with proven systems, sticky long-term contracts, and a loyal customer base. The owners are committed to a 1–2 year transition to ensure continuity and knowledge transfer. If you’re an acquisition entrepreneur, search fund, or investor interested in learning more, feel free to DM me for the teaser & introduction to the broker.